May 21, 2020
ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer
May 12, 2020
Syndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
May 07, 2020
Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update
Apr 30, 2020
Syndax Announces Pricing of Public Offering of Common Stock
Apr 30, 2020
Syndax to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 7, 2020
Apr 29, 2020
Syndax Announces Proposed Public Offering of Common Stock
Apr 27, 2020
Syndax Pharmaceuticals Announces Preclinical Profile and Initial Phase 1 Data Demonstrating Clinical Activity of Menin Inhibitor SNDX-5613 in Adults with Relapsed/Refractory Acute Leukemias
Apr 14, 2020
Syndax Pharmaceuticals Announces Three Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting
Mar 03, 2020
Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update
Feb 18, 2020
Syndax Announces Participation at Two Upcoming Investor Conferences
Jan 31, 2020
Syndax Announces $35.0 Million Offering of Common Stock and Enters Term Sheet for Loan with Hercules Capital for up to $30 Million
Jan 10, 2020
Syndax Pharmaceuticals Highlights 2020 Clinical and Corporate Outlook
Dec 10, 2019
Syndax Pharmaceuticals Announces Plans to Commence Phase 2 Expansion Cohort of SNDX-6352 for the Treatment of Chronic Graft Versus Host Disease
Dec 09, 2019
Syndax Announces Preclinical Results Supporting Development of its Portfolio of Menin Inhibitors In Mixed Lineage Leukemias
Nov 07, 2019
Syndax Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Business Update
Nov 06, 2019
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
Oct 31, 2019
Syndax to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 7, 2019
Aug 28, 2019
Syndax Announces Participation at Four Upcoming Investor Conferences
Aug 05, 2019
Syndax to Participate in the BTIG Biotechnology Conference
Jul 31, 2019
Syndax to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 7, 2019